drugset / Trial / NCT01444846

Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift

NCT01444846 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Exposure to loud sounds can cause hearing loss. The purpose of this research study is to evaluate potential prevention of temporary changes in hearing that may occur after listening to music through an iPod or personal music player. We will measure temporary changes in hearing in subjects who listen to music and take either the study drug, SPI-1005, or a placebo for 4 days. SPI-1005 is a proprietary preparation of ebselen that allows it to be taken by mouth. Ebselen contains the mineral selenium and behaves like Glutathione Peroxidase, an enzyme that helps to rid the body of damaging chemicals caused by loud sounds.

Timeline

Start
2011-09
Primary completion
2013-12
Completion
2014-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ebselen Small molecule 200 mg Oral
Comparator Ebselen Small molecule 400 mg Oral
Comparator Ebselen Small molecule 600 mg Oral

Indications